 |
 |
|
| 2010 Competition |
| Case Background |
| Case Guidelines |
| Competition Timeline |
| Submission |
| Contact Us |
| View the 2009 Competition |
| View the 2008 Competition |
| Health Enterprise Management Club, Social Enterprise, at Kellogg 2010 Social Entrepreneurship in Health and Wellness Competition |
 |
| Part 1 - Introduction |
 |
| Part 2 - Sponsors |
 |
| Part 3 - Guidelines |
| The CHEST Foundation and the Kellogg School of Management Case Competition 2010 Chronic diseases, including diabetes, affect more than 162 million individuals (55.8%) in the United States. These conditions shorten lives, reduce quality of life, and create considerable burden for caregivers. In 2003, the total cost (treatment expenditure plus lost productivity) was $1,323.7 billion, and it is projected to be $4,130.0 billion by 2023 if no improvements are made to the current system.1 The design of innovative methods for the care and management of chronic illnesses will have a significant impact both on patients and the US economy. The 2010 Social Entrepreneurship in Health & Wellness Competition will focus on diabetes, the prevalence of which continues to rise (a 9.8% compound annual growth rate from 2003 to 2009).1,2 Diabetes is being called the epidemic of the 21st century.3 As a chronic illness with many interrelated influence factors, diabetes is a difficult disease to manage. One method for improving outcomes and reducing economic burden is by applying a chronic care model, as developed by the Institute for Healthcare Improvement (IHI). The chronic care model uses evidence-based, guideline-driven models of care for primary care physicians and other health-care providers that encourage high quality chronic disease management.4 Research also has indicated that management of chronic illness results in improved outcomes when there are links between the provider, patient, and community resources.4 Chronic care treatment models often seek to achieve patient compliance through empowerment. Successful examples of empowering patients to participate in their care include the development of the insulin pump and education aimed at understanding food labels. Despite these successes, diabetes proves to be particularly challenging to manage due to the multiple lifestyle changes required.
The Competition The Carol and Larry Levy Social Entrepreneurship Lab and the Health Enterprise Management Program at Kellogg are partnering with the CHEST Foundation, American Diabetes Association and Medtronic to sponsor a competition to promote the development of practical business models to improve the outcome of patients with diabetes. Successful plans will not only promise better outcomes for diabetes care, but also will be suggestive of approaches that might work across a wide range of chronic illnesses. The competition is open to teams of graduate students currently enrolled at Northwestern University. Each team must include at least one student who is enrolled in the Kellogg School of Management. The competition will be judged by a panel of distinguished judges and conclude in mid-May. At the conclusion of the competition, two teams will be selected as finalists and give featured presentations at an awards dinner that will be attended by the judges, as well as leaders and potential investors from the community, business, and government. At the conclusion of the dinner, the panel of judges will decide on a winner and a runner-up. The winning team will receive $7,000, and the runner-up will receive $3,000. Proposals should address diabetes management from a provider and patient perspective. Proposals should include a statement of objectives, an evaluation of similar efforts undertaken elsewhere, anticipated impacts on stakeholders, organizational structure, resource requirements (money, personnel, and tangible assets), budgets, sources of sustainable funding, and measurable criteria for success. The best proposals should have high value added over current approaches and offer a clear path to implementation. Ideally, proposals will have a turnkey quality: aside from financial backing, there should be no additional steps required to implement the proposal. Teams will have access to experts in medical research and diabetes education, as well as in other aspects of the medical and biotechnology industry. |